INKON Life Technology Co Ltd
SZSE:300143

Watchlist Manager
INKON Life Technology Co Ltd Logo
INKON Life Technology Co Ltd
SZSE:300143
Watchlist
Price: 9.97 CNY -1.48%
Market Cap: 7.5B CNY

INKON Life Technology Co Ltd
Accounts Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

INKON Life Technology Co Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
INKON Life Technology Co Ltd
SZSE:300143
Accounts Receivables
ÂĄ295.1m
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
29%
A
Aier Eye Hospital Group Co Ltd
SZSE:300015
Accounts Receivables
ÂĄ2.2B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
26%
I
Innovative Medical Management Co Ltd
SZSE:002173
Accounts Receivables
ÂĄ74.9m
CAGR 3-Years
-10%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
X
XiAn International Medical Investment Co Ltd
SZSE:000516
Accounts Receivables
ÂĄ594.2m
CAGR 3-Years
9%
CAGR 5-Years
25%
CAGR 10-Years
29%
H
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
Accounts Receivables
ÂĄ286.1m
CAGR 3-Years
15%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Sanbo Hospital Management Group Ltd
SZSE:301293
Accounts Receivables
ÂĄ120.4m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

INKON Life Technology Co Ltd
Glance View

Market Cap
7.4B CNY
Industry
Health Care

INKON Life Technology Co., Ltd. engages in the research, development, production and sale of edible fungus. The company is headquartered in Qingdao, Shandong and currently employs 1,791 full-time employees. The company went IPO on 2011-04-22. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The firm is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
8.98 CNY
Overvaluation 10%
Intrinsic Value
Price

See Also

What is INKON Life Technology Co Ltd's Accounts Receivables?
Accounts Receivables
295.1m CNY

Based on the financial report for Sep 30, 2025, INKON Life Technology Co Ltd's Accounts Receivables amounts to 295.1m CNY.

What is INKON Life Technology Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
29%

Over the last year, the Accounts Receivables growth was 28%. The average annual Accounts Receivables growth rates for INKON Life Technology Co Ltd have been 15% over the past three years , 9% over the past five years , and 29% over the past ten years .

Back to Top